Cite
HARVARD Citation
Schreiber, S. et al. (n.d.). DOP37 Efficacy and safety of filgotinib in patients with Ulcerative Colitis stratified by age: Post hoc analysis of the phase 2b/3 SELECTION and SELECTIONLTE studies. Journal of Crohn's and colitis. pp. i085-i087. [Online].